首页> 外文期刊>Contrast media & molecular imaging >Fast clearing RGDa??based neara??infrared fluorescent probes for in vivo tumor diagnosis
【24h】

Fast clearing RGDa??based neara??infrared fluorescent probes for in vivo tumor diagnosis

机译:快速清除基于RGDa™的近红外荧光探针用于体内肿瘤诊断

获取原文
获取外文期刊封面目录资料

摘要

A fast clearing hydrophilic neara??infrared (NIR) dye ICGa??Dera??02 was used to constitute tumor targeting contrast agents. Cell adhesion molecule integrin ?±v?23 served as the target receptor because of its unique expression on almost all sprouting tumor vasculatures. The purpose of this study was to synthesize and compare the properties of integrin ?±v?23a??targeted, fast clearing NIR probes both in vitro and in vivo for tumor diagnosis. ICGa??Dera??02 was covalently conjugated to three kinds of RGD peptide including linear, monoeric cyclic and dimeric RGD to form three RGDa??based NIR probes. The integrin receptor specificities of these probes were evaluated in vitro by confocal microscopy. The dynamic bioa??distribution and elimination ratse were in vivo reala??time monitored by a neara??infrared imaging system in normal mice. Further, the in vivo tumor targeting abilities of the RGDa??based NIR probes were compared in ?±v?23a??positive MDAa??MBa??231, U87MG and ?±v?23a??negtive MCFa??7 xenograft mice models. Three RGDa??based NIR probes were successfully synthesized with good optical properties. In vitro cellular experiments indicated that the probes have a clear binding affinity to ?±???23a??positive tumor cells, with a cyclic dimeric RGD probe owing the highest integrin affinity. Dynamic bioa??distributions of these probes showed a rapid clearing rate through the renal pathway. In vivo tumor targeting ability of the RGDa??based porbes was demonstrated on MDAa??MBa??231 and U87MG tumor models. As expected, the c(RGDyK)2a??ICGa??Dera??02 probe displayed the highest tumora??toa??normal tissue contrast. The in vitro and in vivo block experiments confirmed the receptor binding specificity of the probes. The hydrophilic dyea??labeled NIR probes exhibited a fast clearing rate and deep tissue penetration capability. Further, the ?±???23 receptor affinity of the three RGDa??based NIR probes followed the order of dimer cyclic monomer cyclic linear. The results demonstrate potent fast clearing probes for in vivo early tumor diagnosis. Copyright ?? 2012 John Wiley & Sons, Ltd.
机译:一种快速清除的亲水性近红外(NIR)染料ICGa 10 Dera 12 O 2被用来构成靶向肿瘤的造影剂。细胞粘附分子整联蛋白α±vβ23由于几乎在所有发芽的肿瘤脉管系统中独特表达而成为靶受体。这项研究的目的是在体内和体外合成并比较以整联蛋白α±vα23aβ为靶的快速清除NIR探针的特性。将ICGa 12 Dera 125 02共价结合到三种RGD肽上,包括线性,单双环和二聚RGD,以形成三种基于RGDa 18的NIR探针。通过共聚焦显微镜在体外评估这些探针的整联蛋白受体特异性。在正常小鼠中,通过近红外成像系统对体内动态生物分布和消除大鼠进行实时监测。此外,在α±vβ23aβ阳性MDAaβMBaβ231,U87MG和β±vβ23aβ阴性MCFaβ7异种移植物中比较了基于RGDaβ的NIR探针的体内肿瘤靶向能力。小鼠模型。成功地合成了三种具有良好光学性质的基于RGDaβ的NIR探针。体外细胞实验表明,这些探针对α±23αβ阳性肿瘤细胞具有明显的结合亲和力,而环状二聚体RGD探针具有最高的整联蛋白亲和力。这些探针的动态生物区分布显示出通过肾脏途径的快速清除率。在MDAaβ,MBaβ231和U87MG肿瘤模型上证实了基于RGDaβ的管的体内肿瘤靶向能力。如所期望的,c(RGDyK)2a -ICGa -Dera -02探针显示出最高的肿瘤-to-α-正常组织对比度。体外和体内阻断实验证实了探针的受体结合特异性。亲水性染料标记的NIR探针显示出快速的清除速率和深层的组织穿透能力。另外,三种基于RGDaβ的NIR探针的α±β23受体亲和力遵循二聚环>单体环>线性的顺序。结果证明了用于体内早期肿瘤诊断的有效的快速清除探针。版权?? 2012年John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号